Weekly funding picks, May 4–10: resilient navigation, embedded credit and high-power storage
ANELLO scales navigation production, CredibleX raises equity for SME lending infrastructure, and Skeleton closes an initial €33 million.
ANELLO Photonics secured an additional $25 million in a Series B-2 announced May 4, led by MESH. Washington Harbour Partners joined existing investors.
The funding will accelerate production and broader deployment of navigation systems for autonomous platforms on land, at sea and in the air. Its silicon-photonics optical gyroscope brings inertial navigation into a compact, manufacturable form.
CredibleX adds equity alongside its lending facility
CredibleX announced a $15 million Series A on May 6, led by Mubadala through its MENA Venture Capital Fund, with Further Ventures participating. The new equity follows a separate $100 million senior secured facility in 2025.
The UAE lender will expand distribution partnerships and its lending marketplace while improving technology and data capabilities. It embeds working-capital products in networks already used by small and medium-sized businesses.
Skeleton’s first close supports power systems and manufacturing
Skeleton Technologies announced an initial €33 million close of a larger pre-IPO financing on May 7. Axon Partners Group, SmartCap and Taiwania Capital joined its investor base.
The funding supports high-power energy storage for AI data centres and grids. Alongside manufacturing in Germany and Finland, the company was preparing a US production expansion and a proposed US listing in 2027.
The selected financings
Sources
All rounds in this edition
| Company | Amount | Round | Sector · country | Investors | Date |
|---|---|---|---|---|---|
| CHOSEN CHOSEN develops skincare, haircare and supplements for melanin-rich skin and Indian environmental conditions. | $5M | Series A | Consumer · India | Alkemi Growth Capital, Avnish Anand, Fireside Ventures (lead), BOLD | |
| Enzo Health AI-driven platform automating home health workflows from referral to reimbursement for post-acute care providers | $20M | Series A | Healthtech · United States | Rigby Watts, Tandem Ventures, N47, Gradient | |
| Latus Bio, Inc. Engineers scalable AAV gene therapies for CNS and rare diseases including Huntington's disease and CLN2 | $97M | Series A | Biotech · United States | Helen's Pink Sky Foundation, DCVC Bio, BioAdvance, Hatch BioFund, 8VC, Modi Ventures, Korea Development Bank, Gaingels, Benjamin Franklin Technology Partners |